← Back to Search

Stent Graft

Stent Graft for Aortic Dissection

N/A
Waitlist Available
Research Sponsored by W.L.Gore & Associates
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary entry tear must be in the ascending aorta and ≥2cm distal to the most distal coronary artery ostia
Adequate vascular access via transfemoral or retroperitoneal approach
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days, 6 months, and 12 months post procedure
Awards & highlights

Study Summary

This trial assesses if a stent graft can be used to treat aortic dissections, a potentially life-threatening medical condition.

Who is the study for?
This trial is for individuals at high surgical risk with DeBakey Type I/II aortic dissection who can follow the study's protocol and undergo CT scans. They must have an aorta size compatible with the GORE® Stent Graft, and not require certain heart procedures within 30 days. Exclusions include drug abuse history, pregnancy, allergies to device materials, previous thoracic surgery, connective tissue diseases, poor imaging due to body habitus or conditions preventing clear visualization of the aorta.Check my eligibility
What is being tested?
The ARISE trial is evaluating how well the GORE® Ascending Stent Graft works in treating DeBakey Type I/II aortic dissections. This involves placing a stent graft within the ascending part of the aorta where there's been separation (dissection) between layers of its wall.See study design
What are the potential side effects?
While specific side effects are not listed here, similar procedures may involve risks like bleeding, infection at access sites, allergic reactions to materials or contrast media used during implantation and potential complications related to placement such as movement or damage to surrounding structures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My aortic tear starts beyond 2cm from where the heart's arteries begin.
Select...
I can have procedures done through my groin or belly area.
Select...
My aortic dissection type fits the treatment with GORE® Stent.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days, 6 months, and 12 months post procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days, 6 months, and 12 months post procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
All Cause Mortality at 30 Days Post-procedure
Secondary outcome measures
Aorta-related Mortality
Endoleak Assessed Through 1 Month, 6 Months, and 12 Months
Individual MACCE Components Through 30 Days, 6 Months, and 12 Months
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: GORE® Ascending Stent GraftExperimental Treatment1 Intervention
Treatment with the GORE® Ascending Stent Graft

Find a Location

Who is running the clinical trial?

W.L.Gore & AssociatesLead Sponsor
95 Previous Clinical Trials
28,312 Total Patients Enrolled
5 Trials studying Aortic Dissection
835 Patients Enrolled for Aortic Dissection

Media Library

GORE® Ascending Stent Graft (Stent Graft) Clinical Trial Eligibility Overview. Trial Name: NCT02380716 — N/A
Aortic Dissection Research Study Groups: GORE® Ascending Stent Graft
Aortic Dissection Clinical Trial 2023: GORE® Ascending Stent Graft Highlights & Side Effects. Trial Name: NCT02380716 — N/A
GORE® Ascending Stent Graft (Stent Graft) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02380716 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available spaces left for individuals to join this examination?

"Unfortunately, clinicaltrials.gov reveals that this trial is not presently recruiting any participants; it was first posted on August 1st 2015 and its information was last updated on February 24th 2023. Nonetheless, 48 other trials are currently inviting individuals to join them in their research efforts."

Answered by AI
~2 spots leftby Apr 2025